Target Organ and Levels of Evidence for TR-584
Toxicology Studies of Indole-3-Carbinol (CASRN 700-06-1) in F344/N Rats and B6C3F1/N Mice and Toxicology and Carcinogenesis Studies of Indole-3-Carbinol in Harlan Sprague Dawley Rats and B6C3F1/N Mice (Gavage Studies)
Chemical CASRN (Study Title) |
Peer Review Date | Primary Uses | Route/Exposure Levels | Study Laboratory |
---|---|---|---|---|
Indole-3-carbinol 700-06-1 |
05/22/2014 | Natural component of brassica vegetables; marketed as a dietary supplement and cancer preventative agent | Gavage R: 0, 75, 150, or 300 mg/kg; M: 0, 62.5, 125, or 250 mg/kg; 50/sex/species/dose |
Battelle Columbus Laboratory |
Levels of Evidence
Male Rats: No Evidence
Type | Organ/Tissue (Lesion) |
---|---|
Non-Neoplastic Lesions |
|
Female Rats: Some Evidence
Type | Organ/Tissue (Lesion) |
---|---|
Neoplastic Lesions |
|
May Have Been Related |
|
Non-Neoplastic Lesions |
|
Male Mice: Clear Evidence
Type | Organ/Tissue (Lesion) |
---|---|
Neoplastic Lesions |
|
Non-Neoplastic Lesions |
|
Female Mice: No Evidence
Type | Organ/Tissue (Lesion) |
---|---|
Non-Neoplastic Lesions |
|